Hin Sang Group (International) Holding Co. Ltd. (HK:6893)
:6893
Want to see HK:6893 full AI Analyst Report?
6893 Stock Chart & Stats
HK$0.28
HK$0.03(15.04%)
At close: 4:00 PM EST
HK$0.28
HK$0.03(15.04%)
Day’s Range― - ―
52-Week RangeHK$0.09 - HK$0.42
Previous CloseN/A
Volume2.00K
Average Volume (3M)146.87K
Market Cap
HK$148.48M
Enterprise ValueHK$646.17M
Total Cash (Recent Filing)HK$19.87M
Total Debt (Recent Filing)HK$344.41M
Price to Earnings (P/E)―
Beta0.29
Next Earnings
Jun 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding1,091,796,000
10 Day Avg. Volume47,000
30 Day Avg. Volume146,866
Financial Highlights & Ratios
PEG Ratio-0.13
Price to Book (P/B)1.46
Price to Sales (P/S)2.47
P/FCF Ratio-53.15
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained revenue growth of ~10.4% shows the company is expanding top-line traction in its category, a durable sign of demand and distribution execution. If management controls operating costs, this revenue base can support scaling and eventual margin recovery over the next several quarters.
Gross ProfitabilityA relatively healthy gross margin provides structural room to absorb SG&A and invest in product or distribution improvements. In household and personal products, above-baseline gross margins can sustain profitability if operating expenses are rationalized, aiding long-term margin recovery.
Moderate Equity RatioA moderate equity ratio indicates a non-trivial equity base backing assets, which offers some balance-sheet stability versus pure debt financing. This structural cushion can improve resilience to shocks and help preserve access to capital while the company works to address leverage and cash generation.
Bears Say
Persistent LossesOngoing net losses and negative operating margins are a structural concern: they erode equity and limit the company's ability to self-fund investment. Over a multi-quarter horizon, persistent unprofitability undermines sustainability and raises the urgency for durable cost or revenue improvements.
High LeverageA debt-to-equity ratio above 2 creates meaningful fixed obligations and refinancing risk. Combined with weak profitability, high leverage constrains strategic flexibility, increases interest sensitivity, and heightens the risk of covenant stress or forced capital raises over the medium term.
Weak Cash GenerationNegative free cash flow growth and poor conversion of income to operating cash indicate structural liquidity weakness. Without generating positive cash internally, the company will likely rely on external financing, which can be dilutive or costly and impair its ability to invest in growth initiatives.
Hin Sang Group (International) Holding Co. Ltd. News
6893 FAQ
What was Hin Sang Group (International) Holding Co. Ltd.’s price range in the past 12 months?
Hin Sang Group (International) Holding Co. Ltd. lowest stock price was HK$0.09 and its highest was HK$0.41 in the past 12 months.
What is Hin Sang Group (International) Holding Co. Ltd.’s market cap?
Hin Sang Group (International) Holding Co. Ltd.’s market cap is HK$148.48M.
When is Hin Sang Group (International) Holding Co. Ltd.’s upcoming earnings report date?
Hin Sang Group (International) Holding Co. Ltd.’s upcoming earnings report date is Jun 25, 2026 which is in 36 days.
How were Hin Sang Group (International) Holding Co. Ltd.’s earnings last quarter?
Hin Sang Group (International) Holding Co. Ltd. released its earnings results on Nov 27, 2025. The company reported -HK$0.009 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.009.
Is Hin Sang Group (International) Holding Co. Ltd. overvalued?
According to Wall Street analysts Hin Sang Group (International) Holding Co. Ltd.’s price is currently Overvalued.
Does Hin Sang Group (International) Holding Co. Ltd. pay dividends?
Hin Sang Group (International) Holding Co. Ltd. pays a Quarterly dividend of HK$0.01 which represents an annual dividend yield of N/A. See more information on Hin Sang Group (International) Holding Co. Ltd. dividends here
What is Hin Sang Group (International) Holding Co. Ltd.’s EPS estimate?
Hin Sang Group (International) Holding Co. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hin Sang Group (International) Holding Co. Ltd. have?
Hin Sang Group (International) Holding Co. Ltd. has 1,091,796,000 shares outstanding.
What happened to Hin Sang Group (International) Holding Co. Ltd.’s price movement after its last earnings report?
Hin Sang Group (International) Holding Co. Ltd. reported an EPS of -HK$0.009 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.923%.
Which hedge fund is a major shareholder of Hin Sang Group (International) Holding Co. Ltd.?
Currently, no hedge funds are holding shares in HK:6893
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Hin Sang Group (International) Holding Co. Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
0.00%
12-Months-Change
Fundamentals
Return on Equity
-27.00%
Trailing 12-Months
Asset Growth
-10.23%
Trailing 12-Months
Company Description
Hin Sang Group (International) Holding Co. Ltd.
Hin Sang Group (International) Holding Co. Ltd., together with its subsidiaries, primarily engages in the manufacture, marketing, and sale of healthcare products primarily targeting at children in Hong Kong and Mainland China. The company operates through four segments: Product Development, Brand Development and Management, Trading of Goods, and Healthcare. The Product Development segment develops and sells personal care products, household products, and health supplements under the Hin Sang, Tai Wo Tong, Cheers Smart, Care Plus, Shuang Long, and King's Antiseptic brand names. The Brand Development and Management segment engages in marketing, selling and distribution, logistics, and delivery services of personal care products under the Pahmi, Enear, Vcnic, Zici, and Sunew brand names; and manages and develops brands for its brand proprietors. The Trading of Goods segment engages in the distribution and sale of skin care products, personal care products, and household products purchased from various authorized dealers, independent traders, manufacturers, parallel importers, and suppliers. The Healthcare segment provides Chinese medical healthcare related services for mothers and children; develops mother and child related health products; and hospital, medical center, and related services. It is also involved in the trading of skin care, personal care, and slimming products; and property holding business. The company sells its products in Hong Kong, as well as sells through a network of distributors in the People's Republic of China and Macau. It also sells its products online. The company was founded in 1996 and is headquartered in Tsim Sha Tsui, Hong Kong. Hin Sang Group (International) Holding Co. Ltd. is a subsidiary of Genwealth Group Holding Company Limited.
Hin Sang Group (International) Holding Co. Ltd. (6893) Earnings & Revenues
Technical Analysis
Fourace Industries Group Holdings Limited
―
Evergreen Products Group Ltd.
―
China Ludao Technology Co. Ltd.
―
Nanjing Sinolife United Co., Ltd. Class H
―